BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7362556)

  • 1. Blockade of the different enzymatic steps in the synthesis of brain amines and memory (CAR) in hypobaric hypoxic rats treated and untreated with L. dopa.
    Boismare F; Le Poncin-Lafitte M; Rapin JR
    Aviat Space Environ Med; 1980 Feb; 51(2):126-8. PubMed ID: 7362556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
    Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impairment of learning of conditioned avoidance response in rats after 6-hydroxydopamine.
    Plech A; Herman ZS; Brus R; Drybanski A
    Act Nerv Super (Praha); 1975 Sep; 17(3):176-8. PubMed ID: 1199684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and chronic treatment with L-dopa on catecholamine turnover in the rat brain.
    Yamanaka Y; Kono S
    Hiroshima J Med Sci; 1977 Mar; 26(1):39-44. PubMed ID: 903270
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of m-cholinoblockaders and physostigmine on emotional reactivity and catecholamine metabolism in the brain of rats].
    Zharkovskiĭ AM; Allikmets LKh; Annuk KE
    Farmakol Toksikol; 1978; 41(1):28-32. PubMed ID: 564287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased efficacy of teturam combined with L-DOPA in experimental alcoholism in the rat].
    Gromova EA; Khesin II; Bobkova NV; Plakkhinas LA; Tokareva AE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1226-31. PubMed ID: 3022507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hypobaric hypoxia: central catecholamine levels and cortical PO2 and avoidance response in rats treated with apomorphine.
    Saligaut C; Moore N; Boulu R; Plotkine M; Leclerc JL; Prioux-Guyonneau M; Boismare F
    Aviat Space Environ Med; 1981 Mar; 52(3):166-70. PubMed ID: 7225019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
    Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL
    J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between memory enhancement induced by nitric oxide donor and brain ADP-ribosyltransferase in rats].
    Li CD; Zhang SY; Yuan B
    Sheng Li Xue Bao; 2000 Dec; 52(6):507-10. PubMed ID: 11941417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of external factors on biogenic cerebral amines].
    Schrammowa H; Rybakowski J
    Psychiatr Pol; 1972; 6(2):225-7. PubMed ID: 4402133
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
    Sonkusare S; Srinivasan K; Kaul C; Ramarao P
    Life Sci; 2005 May; 77(1):1-14. PubMed ID: 15848214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental role for catecholamines in Drosophila behavior.
    Pendleton RG; Rasheed A; Paluru P; Joyner J; Jerome N; Meyers RD; Hillman R
    Pharmacol Biochem Behav; 2005 Aug; 81(4):849-53. PubMed ID: 16051344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic mechanism--monoamines relation in certain brain structures.
    Izquierdo JA
    Prog Drug Res; 1972; 16():334-63. PubMed ID: 4405290
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats.
    Barhwal K; Singh SB; Hota SK; Jayalakshmi K; Ilavazhagan G
    Eur J Pharmacol; 2007 Sep; 570(1-3):97-107. PubMed ID: 17610872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.